Pridopidine Phase 3 Study to Evaluate Efficacy and Safety in ALS
Pridopidine Phase 3 Study to Evaluate Efficacy and Safety in ALS
Recruiting · NCT07322003 · Registry updated 2026-10-06Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Pridopidine Phase 3 Study to Evaluate Efficacy and Safety in ALS | Nutritional and Metabolic Diseases, TDP-43 proteinopathy, amyotrophic lateral sclerosis, central nervous system disorder, metabolic disease, motor neuron disorder, nervous system disorder, neurodegenerative disease, neuromuscular disease, proteostasis deficiencies, spinal cord disorder | Recruiting | Phase 3 | 2026-10-06 | NCT07322003 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Ferrer Internacional S.A. | 4 |
| Prilenia | 2 |
55 results · Page 1 of 3
Research sites
Swipe the table sideways for more columns.